Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares OutstandingShort-Term Debt issuances
Ratios

Aytu Biopharma (AYTU) Short-Term Debt repayments (2021 - 2022)

Historic Short-Term Debt repayments for Aytu Biopharma (AYTU) over the last 5 years, with Q3 2022 value amounting to $30.5 million.

  • Aytu Biopharma's Short-Term Debt repayments fell 3311.49% to $30.5 million in Q3 2022 from the same period last year, while for Sep 2022 it was $163.5 million, marking a year-over-year change of. This contributed to the annual value of $156.4 million for FY2022, which is 18966.26% up from last year.
  • Latest data reveals that Aytu Biopharma reported Short-Term Debt repayments of $30.5 million as of Q3 2022, which was down 3311.49% from $39.3 million recorded in Q2 2022.
  • In the past 5 years, Aytu Biopharma's Short-Term Debt repayments ranged from a high of $48.0 million in Q2 2021 and a low of $30.5 million during Q3 2022